Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-11-01T15:30:14.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A notice was added announcing NIH website updates and explaining that some NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.3%
    Check dated 2026-10-25T14:32:22.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s website revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-18T14:51:15.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer now identifies the website as revision v3.7.1 instead of v3.7.0.
    Difference
    0.0%
    Check dated 2026-10-11T14:30:06.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The revision label updates from v3.6.6 to v3.7.0 in the study record history display, indicating a newer version of the page. This change is a metadata update and does not modify any study data or content.
    Difference
    0.0%
    Check dated 2026-09-20T19:58:59.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The history view now shows Revision: v3.6.6 instead of v3.6.5, indicating a small frontend update to the page.
    Difference
    0.0%
    Check dated 2026-08-30T08:13:13.000Z thumbnail image

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.